Adaptive Biotechnologies
Jeff Ostrofsky is a seasoned professional in the pharmaceutical and biotechnology industries, currently serving as a Senior Diagnostic Hematology Specialist at Adaptive Biotechnologies Corp. since January 2021. In this role, Ostrofsky is responsible for implementing clonoSEQ across key medical institutions in Michigan and Ohio. Prior experience includes a tenure at Amgen as a Senior Oncology Specialist, where remarkable growth in sales for Kyprolis was achieved. Ostrofsky's background further encompasses roles at Sanofi where expertise in hospital account management was demonstrated, and at GlaxoSmithKline as an Oncology Account Manager, significantly driving sales of cancer treatments. With a BA from Michigan State University, Ostrofsky brings extensive experience and a proven track record of success in sales and account management within the healthcare sector.
This person is not in any teams
This person is not in any offices
Adaptive Biotechnologies
17 followers
Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems. Adaptive’s proprietary immune profiling platform reveals and translates insights from our adaptive immune systems with unprecedented scale and precision.